3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Brain Neoplasms
14
Prostatic Neoplasms
7
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
3
Radiation Injuries
2
Pancreatic Neoplasms
2
Neuroma, Acoustic
2
Meningioma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Stereotactic Body Radiation Therapy (SBRT)
1
Spine Metastasis
1
Spinal Neoplasms
1
Spinal Bone Metastases
1
Radiotherapy
1
Pituitary Neoplasms
1
Ototoxicity
1
Neoplasms
1
Lymphatic Metastasis
1
Hypopituitarism
1
Hearing Loss
1
Head and Neck Neoplasms
1
Fatigue
1
Disease Progression
1
Depression
1
Cognitive Dysfunction
1
Cognition Disorders
1
Central Nervous System Neoplasms
1
Interventions
Methadone
2
oxycodone naloxone combination
1
Tapentadol
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Pharmacogenomic Testing
1
Oxycodone
1
Morphine
1
Interviews as Topic
1
Hydromorphone
1
Focus Groups
1
Fentanyl
1
Diagnostic Tests, Routine
1
Buprenorphine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Cancer Pain
×
Radiosurgery
×
Clear all
NCT04595032
2024-11-07
MAMETIC
National Cancer Institute, Naples
Completed
3,234 enrolled